Anti Acne Treatment Market Size Projected to Reach $15.82 billion by 2034 | 4.56%

Straits Research, a leading market research organization, announced the release of the report titled “Anti Acne Treatment Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to Straits Research, the global anti acne treatment market size was valued at $10.63 billion in 2025 and is expected to reach $15.82 billion by 2034, registering a CAGR of 4.56% during the forecast period (2026–2034).

The anti acne treatment market is segmented based on type of acne, therapeutic class, route of administration and region. Some of the insights provided in the report are highlighted below:

• The hormonal segment dominated the market with the largest share of 43.45% in 2025.
• North America is expected to lead the anti-acne treatment market during the forecast period, supported by early adoption of advanced dermatological therapies and widespread access to prescription and over-the-counter treatment options.
• Healthcare providers globally are increasingly shifting toward combination and targeted anti-acne treatment approaches to improve clinical outcomes for long-term acne management.
• India is projected to emerge as a leading market in the Asia Pacific anti-acne treatment market, driven by a large adolescent and young adult population and expanding private skincare clinics.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

1. By Type of Acne
   1. Inflammatory
   2. Hormonal
   3. Cystic
   4. Postsurgical/Wound
   5. Others
2. By Therapeutic Class
   1. Retinoid
   2. Antibiotic
   3. Hormonal therapy
   4. Combination therapy
   5. Laser therapy
   6. Others
3. By Route of Administration
   1. Topical
   2. Oral
   3. Injectable
4. By Region
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East & Africa
   5. Latin America